Published in Cardiovascular Week, December 5th, 2005
Study 1: Universal use of dual-chamber implantable cardioverter defibrillators (ICDs) is a cost-effective approach.
In a recent study, cardiologists in the United States sought "to determine the least expensive strategy for device selection" in patients receiving ICDs.
"Device cost for a single-chamber ICD is less than an atrioventricular (dual-chamber) ICD (AV-ICD); however, some patients without clinical need for AV-ICD at implantation might require a later upgrade, potentially offsetting the initial cost advantage of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.